

Scores at time of recommendation (April 6, 2026)
2026 Q2 (July 29, 2026)
Markel reported second-quarter 2026 results and filed Form 10-Q. Management continued to message that the 2025 reorganization and refocused strategy were producing results. Underwriting profitability improved and investment income rose. The company emphasized progress on capital returns via buybacks, and investor perception shifted toward appreciating operational stabilization and the benefits of the strategic refocus begun in 2025.
Operating revenues reached $4.0 billion for Q2 2026. Adjusted operating income totaled $436 million for Q2 2026, excluding market movements in the equity portfolio. Share repurchases amounted to $237 million in the quarter and $371 million year to date [1][4].
2026 Q1 (April 28, 2026)
Markel reported first-quarter 2026 results and filed Form 10-Q. Results showed continued recovery in adjusted operating income versus the prior year, reinforcing the narrative that underwriting and investment performance were stabilizing after prior years' reserve and business-mix work. Investors saw improved recurring earnings quality as a foundation for capital allocation through buybacks and dividends.
Adjusted operating income reached $498 million for Q1 2026, a 4% increase versus Q1 2025 [12].
2025
Strategic reorganization and divestitures occurred throughout the year, including the sale or transfer of certain renewal rights in Global Reinsurance and other portfolio changes. Large buyback activity began or accelerated in 2025 as capital allocation shifted to share repurchases.
2025 marked a turning point where management refocused Markel's operating footprint and capital allocation. Investors began to re-evaluate the company from a complex conglomerate toward a more streamlined insurance-centric compounder with active capital returns. Sentiment moved from uncertainty about legacy reserve issues toward cautious optimism as reorganization effects became visible.
Management disclosed that underwriting gross premium volume changes in 2026 excluded the effect of the 2025 sale of renewal rights. Share repurchase activity reported in 2026 referenced $371 million year to date, reflecting the buyback trend begun in 2025 [1].
2024
Markel reported 2024 full-year results and announced acquisitions. In June 2024 the company acquired 98% of Valor Environmental. In September 2024 it acquired a 68% stake in Educational Partners International (EPI). The company continued expanding non-insurance operating businesses while managing insurance underwriting.
Investors viewed Markel's diversification into specialty services—environmental services and education staffing—as part of a strategy to broaden fee-earning businesses outside core insurance. The company's shareholder letter and annual report framed 2024 as continued growth in revenues and an active M&A posture [2][10][11].
2023
Markel reported 2023 financial results showing underwriting results that included favorable and adverse reserve developments. The company disclosed significant reserve strengthening on certain lines covering accident years 2020–2022.
Market attention in 2023 focused on reserve development and prior accident-year trends. After earlier adverse developments the company had to strengthen reserves on impacted lines. Perception moved toward caution about prior years' loss trends while watching management's corrective actions.
Insurance segment results included $38.6 million of net favorable development on prior years' loss reserves, compared to $167.4 million favorable in 2022. The company disclosed significant strengthening of reserves on impacted lines and on accident years 2020–2022 in its 2023 filings and releases [6][15].
2022
Continued reserve reviews and reserve strengthening disclosures occurred for accident years including 2020–2022. Underwriting performance and reserve development remained a central theme in the company narrative and filings.
2022 showed larger favorable development than 2023. Later filings noted the company strengthened reserves for certain lines and accident years through 2022 disclosures [15][6].
2021
Markel navigated post-2020 pandemic insurance market conditions, reporting results and managing investment portfolio and underwriting actions. Capital allocation through dividends and opportunistic buybacks featured in investor communications.
In 2021 investors treated Markel as a long-term insurance compounder with a diversified set of businesses. Optimism about recovery in underwriting margins and investment income supported a compounder narrative, though with attention to balance-sheet conservatism given prior reserve volatility [15][11].
Markel is a specialty insurer that has been operating according to the same playbook for decades: disciplined underwriting in complex niche markets, combined with a long-term oriented investment portfolio. CEO Tom Gayner has managed the company since 1990 and has consistently increased the book value per share over this period. The model works because float from the insurance business serves as cheap capital for investments - a mechanism that has made Berkshire Hathaway great. The share is currently trading at a price-to-book ratio of 1.2x, which is unusually moderate for the quality of the company. Anyone with staying power and looking for quality at a reasonable price will find an easy-to-understand business model with a proven track record here.
Markel operates as a specialty property and casualty insurer and investment-focused holding company. It competes across two distinct channels: specialty P&C insurers on one side and larger diversified insurers that control capital and distribution networks in specialty, reinsurance, and program markets on the other. The competitive landscape centers on underwriting cycles and pricing pressure from established players—Berkshire Hathaway, Arch, Chubb, and W. R. Berkley among them—alongside more agile excess and surplus specialists like Kinsale and RLI. The company faces material risks from underwriting volatility and catastrophic losses, market fluctuations in its investment portfolio, competition for reinsurance capacity that could affect its capital position and ratings, and regulatory or tax shifts that could reshape both its insurance operations and holding-company structure.
Markel Corporation operates as a specialty insurer and investment-oriented holding company, with primary exposure to specialty commercial property and casualty, excess and surplus lines, program business, and reinsurance. Its competitive set includes other specialty-focused and diversified insurers that maintain strong underwriting platforms and substantial investment float, alongside Lloyd's syndicates, managing general agents, and alternative capital providers. The company faces material risks from underwriting volatility driven by catastrophic events and pricing cycles, potential investment portfolio deterioration or insufficient returns, competitive pressure and channel disintermediation from managing general agents and insurtech platforms, and regulatory or capital adequacy changes that could restrict growth or necessitate additional capital raises.
| Company | Ticker |
|---|---|
| Chubb Limited | CB.NYSE |
| The Travelers Companies, Inc. | TRV.NYSE |
| W. R. Berkley Corporation | WRB.NYSE |
| AXIS Capital Holdings Limited | AXS.NYSE |
| RenaissanceRe Holdings Ltd. | RNR.NYSE |
| RLI Corp. | RLI.NYSE |
| Kinsale Capital Group, Inc. | KNSL.NYSE |
Receive hand-picked stock recommendations with detailed analyses every week
Start Free Trial| Period | Markel Corporation | vs DAX | vs S&P 500 (SPY) |
|---|---|---|---|
| 1M | -5.02% | -0.99% | -4.90% |
| 3M | -13.50% | -12.01% | -16.36% |
| 6M | -9.82% | -18.59% | -26.93% |
| 1Y | -10.41% | -15.93% | -26.36% |
| 3Y | +16.30% | -47.47% | -69.07% |
| 5Y | +42.48% | -23.78% | -45.68% |
Receive hand-picked stock recommendations with detailed analyses every week
Start Free TrialHow the company’s key valuation ratios (P/E, P/S, P/B and P/CF) have evolved over time compared to today.
| Period | P/E Ratio | P/S Ratio | P/B Ratio | P/CF Ratio |
|---|---|---|---|---|
| Current | 8.4 | 1.1 | 1.0 | 8.3 |
| 1Y ago | 11.7 | 1.5 | 1.4 | 9.4 |
| 3Y ago | 9.8 | 1.3 | 1.4 | 7.1 |
| 5Y ago | 6.8 | 1.3 | 1.2 | 7.9 |
Long-term record of paid dividends (amount per share and dividend yield at the time of payment).
Historical earnings performance shows how consistently the company meets or exceeds analyst expectations. Forward estimates provide insight into expected profitability and growth trajectory.
Selected income statement, balance sheet and cash flow figures. Annual and quarterly, based on reported IFRS/GAAP financials.
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | 16.59B | 16.75B | 15.71B | 11.81B | 12.92B |
| Operating income (EBIT) | 2.73B | 3.64B | 2.65B | -151.57M | 3.13B |
| Net income | 2.11B | 2.75B | 2.00B | -216.28M | 2.42B |
| Free cash flow | 2.55B | 2.34B | 2.53B | 2.45B | 2.13B |
| Total assets | 68.91B | 47.35B | 43.44B | 63.44B | 48.48B |
| Equity | 18.60B | 16.92B | 14.98B | 37.90B | 14.72B |
| Net debt | 339.11M | 1.45B | 636.35M | -33.80M | 844.15M |